High-Dose Treatment With Autologous Stem Cell Transplantation in Multiple Myeloma: Past, Present, and Future
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 44 (4), 227-233
- https://doi.org/10.1053/j.seminhematol.2007.08.010
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myelomaBlood, 2006
- Poor Outcome With Front-Line Autologous Transplantation in t(4;14) Multiple Myeloma: Low Complete Remission Rate and Short Duration of RemissionJournal of Clinical Oncology, 2006
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expressionBlood, 2003
- Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization‐defined chromosome 13 deletion in multiple myeloma: early results of total therapy IIBritish Journal of Haematology, 2002
- Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myelomaBritish Journal of Haematology, 2002
- Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyBlood, 2001
- Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesBlood, 2000
- High-dose melphalan with autologous bone marrow transplantation for multiple myelomaBlood, 1986
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983